2017
DOI: 10.15244/pjoes/74019
|View full text |Cite
|
Sign up to set email alerts
|

A Parametric Malmquist Analysis of Carbon Emission Performance and Its Dynamic Variation in China’s Thermal Power Generation

Abstract: IntroductionIn response to the challenges arising from global warming and climate change, the Chinese government has made a great effort to control CO 2 emissions in terms of both intensity and amount. In 2015 China promised to lower its carbon intensity by 60-65% by 2030 from the 2005 level and peak its carbon emissions by approximately 2030. The power industry is of vital importance for the accomplishment of these carbon emission reduction targets. As the largest CO 2 emitter among all industries, it consume… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 21 publications
0
3
0
Order By: Relevance
“…Wei et al [7], Du and Mao [8], Peng et al [9], and Wei and Zhang [10] employed the parametric linear programming (PLP) approach. Zhao and Ma [11], Zhang et al [12], Bi et al [13], Wei et al [14], and Xie et al [15] used the data envelopment analysis (DEA) method, while Chen et al [16], Wang and Jiang [17], Qi and Choi [18], Xie et al [19], and Zhang et al [20] applied the stochastic frontier analysis (SFA) approach. However, these existing studies assumed that power plants are consistent with technical homogeneity.…”
Section: Introductionmentioning
confidence: 99%
“…Wei et al [7], Du and Mao [8], Peng et al [9], and Wei and Zhang [10] employed the parametric linear programming (PLP) approach. Zhao and Ma [11], Zhang et al [12], Bi et al [13], Wei et al [14], and Xie et al [15] used the data envelopment analysis (DEA) method, while Chen et al [16], Wang and Jiang [17], Qi and Choi [18], Xie et al [19], and Zhang et al [20] applied the stochastic frontier analysis (SFA) approach. However, these existing studies assumed that power plants are consistent with technical homogeneity.…”
Section: Introductionmentioning
confidence: 99%
“…C4‐substituted phthalazin‐1(2 H )‐ones are key structural units ubiquitously found in a number of biologically active compounds displaying diverse pharmacological activities, [1] such as poly‐PARP inhibitor (Olaparib), [1d] histamine H1 receptor antagonist (Azelastine), [1e] aldose reductase inhibitor (Zopolrestat), [1f] Aurora kinase inhibitor, [1g] human A 3 adenosine receptor antagonist [1h] and proteasome inhibitor [1i] (Figure 1), and the nature of substituents present at the C4 positions have an important impact on their pharmacological activities. Accordingly, there has been a long‐standing research interest in the development of efficient methods for the synthesis of these heterocycles, [2,3] and impressive progress has been achieved in access to C4‐(hetero)arylated, [1i,3a–c,f–h,j,l,n–q,u,v] alkylated, [3b,d,e,k,l,u,v] aminated, [1g,3c,i,m,s] alkenylated [3r] and sulfanylated [3t] phthalazin‐1(2 H )‐ones. Recent years have witnessed ever‐growing research efforts within the synthetic community for incorporation of gem ‐difluoromethylene moiety into organic molecules because this group can effectively enhance the biological activities and the physicochemical properties of the parent compounds [4] .…”
Section: Introductionmentioning
confidence: 99%
“…Phthalazinones are becoming increasingly important in the field of drug discovery due to their diverse range of pharmaceutical properties, such as anti-cancer, [319][320][321] anti-inflammatory, [322][323][324] anti-bacterial, 319,325 antioxidant, 319 and anti-neurodegenerative 326 properties. In particular, antibacterial phthalazinones include inosine-5'-monophosphate dehydrogenase inhibitor 206 (Figure 5.4), which has an MBC of 0.94 µM against Francisella tularensis, 327 as well as oxadiazole 207, which inhibit the growth of E. coli and Salmonella typhi.…”
Section: The Phthalazinone Scaffold In Drug Discoverymentioning
confidence: 99%